CRVS vs. TRVI
CRVS (Corvus Pharmaceuticals, Inc.) and TRVI (Trevi Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, CRVS returned 33.63%/yr vs 44.83%/yr for TRVI. At a 0.19 correlation, their price movements are largely independent.
Performance
CRVS vs. TRVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRVS achieves a 54.94% return, which is significantly higher than TRVI's 13.50% return.
CRVS
- 1D
- 2.84%
- 1M
- -24.68%
- YTD
- 54.94%
- 6M
- 42.53%
- 1Y
- 181.37%
- 3Y*
- 53.32%
- 5Y*
- 33.63%
- 10Y*
- 0.06%
TRVI
- 1D
- 5.57%
- 1M
- -6.94%
- YTD
- 13.50%
- 6M
- 11.28%
- 1Y
- 130.31%
- 3Y*
- 75.70%
- 5Y*
- 44.83%
- 10Y*
- —
CRVS vs. TRVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
CRVS Corvus Pharmaceuticals, Inc. | 54.94% | 43.93% | 203.98% | 107.06% | -64.73% | -32.30% | -34.56% | 30.14% |
TRVI Trevi Therapeutics, Inc. | 13.50% | 203.88% | 207.46% | -30.57% | 146.74% | -67.68% | -35.47% | -60.53% |
Correlation
The correlation between CRVS and TRVI is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since May 7, 2019 | 0.19 |
Over the past year, CRVS and TRVI have become more correlated (0.40) than their long-term average of 0.19, meaning their price movements have been converging.
Fundamentals
CRVS:
-$0.53
TRVI:
-$0.43
CRVS:
$0.00
TRVI:
$0.00
CRVS:
-$26.00K
TRVI:
-$31.00K
CRVS:
-$47.43M
TRVI:
-$49.16M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRVS vs. TRVI — Risk / Return Rank
CRVS
TRVI
CRVS vs. TRVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corvus Pharmaceuticals, Inc. (CRVS) and Trevi Therapeutics, Inc. (TRVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRVS | TRVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.16 | ||
| Sortino ratioReturn per unit of downside risk | +1.52 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.35 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 3.23 | 4.44 | -1.21 |
| Martin ratioReturn relative to average drawdown | 7.03 | 10.40 | -3.37 |
Loading charts...
Drawdowns
CRVS vs. TRVI - Drawdown Comparison
The maximum CRVS drawdown since its inception was -96.97%, roughly equal to the maximum TRVI drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for CRVS and TRVI.
Loading charts...
Drawdown Indicators
| CRVS | TRVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.97% | -95.45% | -1.52% |
Max Drawdown (1Y)Largest decline over 1 year | -56.43% | -29.50% | -26.93% |
Max Drawdown (3Y)Largest decline over 3 years | -70.50% | -61.96% | -8.54% |
Max Drawdown (5Y)Largest decline over 5 years | -92.40% | -80.26% | -12.14% |
Max Drawdown (10Y)Largest decline over 10 years | -96.97% | — | — |
Current DrawdownCurrent decline from peak | -53.25% | -7.73% | -45.52% |
Average DrawdownAverage peak-to-trough decline | -69.28% | -61.49% | -7.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.91% | 12.58% | +13.33% |
Volatility
CRVS vs. TRVI - Volatility Comparison
Corvus Pharmaceuticals, Inc. (CRVS) has a higher volatility of 23.12% compared to Trevi Therapeutics, Inc. (TRVI) at 13.78%. This indicates that CRVS's price experiences larger fluctuations and is considered to be riskier than TRVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRVS | TRVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.12% | 13.78% | +9.34% |
Volatility (6M)Calculated over the trailing 6-month period | 111.88% | 39.38% | +72.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 180.64% | 60.39% | +120.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 131.02% | 88.26% | +42.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.13% | 99.35% | +11.78% |
Dividends
CRVS vs. TRVI - Dividend Comparison
Neither CRVS nor TRVI has paid dividends to shareholders.
Financials
CRVS vs. TRVI - Financials Comparison
This section allows you to compare key financial metrics between Corvus Pharmaceuticals, Inc. and Trevi Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRVS and TRVI have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRVS has higher volatility (23.12%) compared to TRVI (13.78%). In terms of maximum drawdown, CRVS dropped -96.97% vs TRVI's -95.45%.
TRVI currently has the higher Sharpe Ratio (2.17 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRVS and TRVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer